Erlotinib treatment results in patients with advanced non-small-cell lung cancer (NSCLC)—Influence of clinical predictors

Authors	SALAJKA F. PEŠEK M. SKŘIČKOVÁ Jana ZATLOUKAL P. KOUBKOVÁ L. GRYGÁRKOVÁ Y. HRNČIARIK M. HEJDUK Karel
Year of publication	2012
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Attached files	Skrickovlung_cancer_004.pdf
Description	The Czech Tarceva Register collects data concerning all NSCLC patients treated with erlotinib in the Czech Republic. Increasing number of classified patients makes possible to analyze factors influencing the treatment results.